COLLABORATION
合作机构
德国慕尼黑Duale Medizin医疗中心
Duale Medizin Medical Center, Munich, Germany
由美国圣地亚哥大学和德国汉堡大学医学博士，国际激素学会的成员，德国肿瘤学会（DGO）董事，慕尼黑Diagnoseklinik”董事，Elke Schwesig-Seebach医生创建的“Duale Medizin医疗新概念，专门致力于系统平衡疗法（内分泌学、功能医学、细胞代谢学）， 慢病风险血液靶向干预技术，抗衰老和肿瘤整体治疗技术的临床应用
合作项目：
● 血液慢病风险靶向干预技术的临床应用
● 维塔恩抗衰老应用研究
● 肿瘤整体治疗技术的临床应用研究
A new concept of Duale Medizin created by the University of San Diego and the University of Hamburg, Germany, a member of the International Hormone Society, a director of the German Society of Oncology (DGO), a director of the Munich Diagnoseklinik, and Dr. Elke Schwesig-Seebach, specializing in systemic balance therapy (endocrinology, functional medicine, cell metabolism), chronic disease risk blood-targeted intervention technology, clinical application of anti-aging and tumor overall treatment technology。 Cooperation projects: Clinical application of targeted intervention techniques for blood chronic disease risk。Vital anti-aging application research。Clinical application research of tumor overall treatment technology
奥地利BIRKMAYER-NADH实验室
奥地利Birkmayer研究所由奥地利维也纳大学教授，国际肿瘤标志学会主席，维也纳生物物理研究所所长(IFBM)，Prof. George Birkmayer NADH 科技公司总裁, George Birkmayer教授为首席科学家团队建立的。主要开展线粒体素在生物体内多酶系统调控，细胞再生、损伤修复和保护的药物开发研究，探讨NADH在细胞生长增殖、信号传递、基因调控、保护线粒体功能、抑制化学毒物的细胞毒作用、修复和逆转细胞损伤中作用机制。开展细胞线粒体素在抗衰老，慢病防控领域的应用研究，并将相关系列产品畅销欧美市场。
合作项目：
● NADH在心脑血管疾病防治中的应用研究
● 生命素（NADH）抗衰老和慢病风险干预多中心协作研究
The Birkmayer Institute in Austria is taught by the University professor，the President of the International Society for tumor marker on Oncology, the President of Prof. George Birkmayer NADH Technologies, and Professor George Birkmayer, the team of chief scientists. It mainly develops mitochondrial enzymes in the regulation of multi-enzyme system, cell regeneration, damage repair and protection in vivo, and explores NADH in cell growth and proliferation, signal transmission, gene regulation, protection of mitochondrial function, inhibition of chemical cytotoxicity, and repair. And reverse the mechanism of action in cell damage. The research and application of cell mitochondrial in the field of anti-aging and chronic disease prevention and control, and the related series of products are sold well in the European and American markets. Cooperation projects: Application of NADH in the prevention and treatment of cardiovascular and cerebrovascular diseases；Biotin (NADH) anti-aging and chronic disease risk intervention multi-center collaborative research
海南省靶向慢病干预与抗衰老研究院
海南省靶向慢病干预与抗衰老研究院是在海南省卫生健康委员会批准和指导下、在海南省民政厅 注册设立得民办非赢利研究机构. 研究院开展慢病干预,、医美、养生,抗衰老相关生物技术研究开发和服务. 开展自然医学,功能医学,预防医疗,量子医学,细胞工程及分子医学相关医药技术研究，咨询、培训，交流. 开展国际慢病防控和抗衰老技术交流机协作研究, 研究院院长张红喜教授曾任解放军第四军医大学西京医院副院长, 第一军医大学珠江医院副院长, 第一军医大学训练部部长. 研究院与美国，英国、挪威诺贝尔奖获得者，德国、奥地利、新西兰等国外一流科学家，国内中国科学院等国内科研院校开展生物技术领域广泛合作，启动10星级标准海南生命谷国际健康绿色生态产业园建设规划，致力于打造国际一流的健康、教育、养生、预防医疗, 养老, 度假、文化旅游、健康管理等全产业链布局的国际绿色生态健康养生和预防医疗园区，提供国际化、高品质、个性化全周期健康服务。
协作项目:
● 国际绿色生态健康养生和预防医疗园区10H建设标准认证
● 维塔恩靶向细胞分子疗法在慢病风险干预的机理研究
● 生命素(NADH)国内外相关研究进展分析报告
The Hainan Provincial Institute for Targeting Chronic Disease Intervention and Anti-Aging is a non-profit research institution established under the approval and guidance of the Hainan Provincial Health and Health Committee and registered in the Civil Affairs Department of Hainan Province. The Institute conducts chronic disease intervention, medical beauty and health care. , anti-aging related biotechnology research and development and services. Conduct natural medicine, functional medicine, preventive medicine, quantum medicine, cell engineering and molecular medicine related medical technology research, consulting, training, exchange. Develop international chronic disease prevention and control and anti-aging technology Professor of Communication Research, Professor Zhang Hongxi, the dean of the Institute, served as the vice president of Xijing Hospital of the Fourth Military Medical University of the People's Liberation Army, the vice president of Zhujiang Hospital of the First Military Medical University, and the training department of the First Military Medical University. The institute and the United States, the United Kingdom, Norway Nobel Prize winners, leading scientists from Germany, Austria, New Zealand, etc., domestic research institutes such as the Chinese Academy of Sciences and other domestic research institutes have carried out extensive cooperation in the field of biotechnology, and initiated the construction of a 10-star standard Hainan Life Valley International Healthy Green Ecological Industrial Park. Create world-class health, education, health care, preventive care, pension, vacation International green ecological health and preventive medical parks with full industrial chain layout such as cultural tourism and health management provide international, high-quality and personalized full-cycle health services.
Cooperation projects: International Green Ecological Health and Preventive Medical Park 10H Construction Standard Certification; Mechanism study of Vital targeted cell molecular therapy in chronic disease risk intervention; Lifeline (NADH) analysis report on relevant research progress at home and abroad
甲状腺结节肿瘤风险干预和治疗国际论坛（IFCRITTN）
甲状腺结节肿瘤风险干预和治疗国际论坛（International Forum on Cancer Risk Intervention and Treatment of Thyroid Nodules，IFCRITTN）是由IHAL针对甲状腺癌防治设置的学术交流论坛，每年由国际健康联盟（IHCA）承办国际甲状腺结节肿瘤风险干预与预防医疗国际论坛，并聘请国际从事甲状腺结节肿瘤风险干预和预防治疗的知名专家担任联盟论坛主席，选举有贡献的专家作为科学委员会常务理事和理事，组织甲状腺结节肿瘤风险干预和防治的科学家，研究员，临床医生和甲状腺三级防控的健康管理者开展学术交流和科学研究协作。
国际甲状腺结节风险干预与防治联盟论坛主题
● 甲状腺癌预防医疗体系的建立
● 甲状腺结节肿瘤风险内环境的干预
● 甲状腺结节微创消融技术的临床应用
● 甲状腺结节微创消融技术临床面对的问题
● 甲状腺结节微创消融技术的疗效评价
● 甲状腺结节肿瘤风险监测和防治大数据库的建立
● 甲状腺结节肿瘤风险干预与预防医疗多中心临床协作
International Forum on Cancer Risk Intervention and Treatment of Thyroid Nodules，IFCRITTN）
International Forum on Cancer Risk Intervention and Treatment of Thyroid Nodules，IFCRITTN）is an academic exchange institution set up by The International Healthcare Allance( IHCA) for the prevention and treatment of thyroid cancer. Every year, IHAL will hosts the International Forum on Risk Intervention and Preventive Medicine of Thyroid Nodules, and invites internationally renowned experts engaged in risk intervention and preventive treatment of Thyroid Nodules to serve as the chairman of the Alliance Forum. Contributing experts are elected as Executive board member and board member of the Scientific Committee. Scientists, researchers, clinicians and health managers of the Alliance for Risk Intervention and Prevention of Thyroid Nodules ,will carry out academic exchanges and scientific research collaboration.
Forum theme
1.Establishment of thyroid cancer prevention medical system
2.Intervention of cancer risk environment of thyroid nodules
3.Clinical application of minimally invasive ablation of thyroid nodules
4.Clinical problems of minimally invasive ablation of thyroid nodules
5.Evaluation of clinical effect of minimally invasive ablation of thyroid nodules
6.Establishment of a large database for cancer risk monitoring and prevention of thyroid nodules
7.Multi-center clinical collaboration of cancer risk intervention and preventive medicine for thyroid nodules
Executive Chairman of the First Forum .
D．G．Brikmayer ，Ph.D., Professor
Jiren Zhang，Ph.D., Professor
Elke Schwesig-Seebach，Professor
